RAPID DIGITAL INNOVATION
SYNAPSE - BOEHRINGER INGELHEIM’S INNOVATION PROGRAM BY BI X
BI X's Synapse program: A platform for external digital innovation that turns bold ideas into practical solutions. Synapse challenges are now live: check them out and apply here.
RAPID DIGITAL INNOVATION
SYNAPSE - BOEHRINGER INGELHEIM’S INNOVATION PROGRAM BY BI X
BI X's Synapse program: A platform for external digital innovation that turns bold ideas into practical solutions. Synapse challenges are now live: check them out and apply here.
WHAT IS SYNAPSE?
Synapse is a collaborative platform that enables companies to partner with Boehringer Ingelheim. Accelerating innovation in partnership with business units to solve critical business challenges, facilitated by BI X.
The program connects the business challenge owners with the company's innovators, evaluates the pilots during a two-day event, and runs the pilots remotely. Results are presented in-person to executives at Boehringer Ingelheim headquarters, all within 6 months.
After initial success in the healthcare field, we realized that this was an area that the team really liked and where our automated inspection technologies made a lot of sense. So, we looked for the best way to develop in the Pharma industry and Synapse is THE reference program in this field. And the fact that the program combines Industry 4.0, co-development, and health, for us it was a winning trio that would allow us to develop. So, we applied
Rodolph Vogt, CEO, M-Cador
WHAT IS SYNAPSE?
Synapse is a collaborative platform that enables companies to partner with Boehringer Ingelheim. Accelerating innovation in partnership with business units to solve critical business challenges, facilitated by BI X.
The program connects the business challenge owners with the company's innovators, evaluates the pilots during a two-day event, and runs the pilots remotely. Results are presented in-person to executives at Boehringer Ingelheim headquarters, all within 6 months.
After initial success in the healthcare field, we realized that this was an area that the team really liked and where our automated inspection technologies made a lot of sense. So, we looked for the best way to develop in the Pharma industry and Synapse is THE reference program in this field. And the fact that the program combines Industry 4.0, co-development, and health, for us it was a winning trio that would allow us to develop. So, we applied
Rodolph Vogt, CEO, M-Cador
WHO IS IT FOR?
We are looking for top companies that can contribute to the topics outlined below. Selected companies will conduct a paid pilot with Boehringer Ingelheim business units this fall with the goal of driving long-term growth through scalable partnerships.
Challenge 1 - Remote patient monitoring
Challenge 2 - AI sales assistant
Challenge 3 - AI-powered conversational insights for IT data
Please read more about challenge 3 in the application form.
WHY JOIN?
27% of startups that have gone through Synapse continue to work with Boehringer Ingelheim beyond the program. This isn't just an accelerator - it's a launching pad for a long-term partnership with one of the world's leading pharmaceutical companies.
Key Dates:
- April 10: Application deadline.
- Early May: Pre-selected companies will participate in an online workshop with Boehringer Ingelheim to outline potential pilot projects.
- May 27-28: Selection of one partner for each challenge during an onsite event in Ingelheim, Germany.
- August - November: Conducting of paid pilot projects by selected companies in collaboration with Boehringer Ingelheim to test and validate use cases.
- November: Innovator’s Showcase Day and evaluation of pilot projects, with presentation of results in Ingelheim, Germany.
What You Should Know:
- The Accelerator Program is free of charge for all participating companies.
- Boehringer Ingelheim and BI X are committed to an open, transparent, and constructive partnership with the companies.
- The upcoming program will end in mid-2026.
What You Should Know:
- The Accelerator Program is free of charge for all participating companies.
- Boehringer Ingelheim and BI X are committed to an open, transparent, and constructive partnership with the companies.
- The upcoming program will end in mid-2026.
Should you have any inquiries, please reach out to the team responsible for the program's operations:
Eero Toppinen
Challenge 1: Remote Patient Monitoring, Email: eero@vertical.vc
Aino Heiska
Challenge 2: AI Sales Assistant, Email: aino@vertical.vc
Bharat Rachupalli
Challenge 3: AI-Powered Conversational Insights for IT Data, Email: bharat@vertical.vc
